• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索激动剂效力的机制:毒蕈碱M3受体处效力与激动剂解离速率之间的关系。

Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor.

作者信息

Sykes David A, Dowling Mark R, Charlton Steven J

机构信息

Novartis Institutes for Biomedical Sciences, Wimblehurst Road, Horsham, West Sussex, UK. .

出版信息

Mol Pharmacol. 2009 Sep;76(3):543-51. doi: 10.1124/mol.108.054452. Epub 2009 Jun 4.

DOI:10.1124/mol.108.054452
PMID:19498041
Abstract

Although there are several empirical approaches that enable the comparison of relative agonist efficacy, the molecular basis that underlies differences in the ability of G protein-coupled receptor agonists to elicit a response is still largely unexplained. Several models have been described that incorporate the kinetics of receptor-mediated initiation of the G protein cycle, but these have not directly addressed the influence of agonist-binding kinetics. To test this, we investigated the relationship between the efficacy of seven M(3) muscarinic receptor agonists and their rate of dissociation (k(off)) from the M(3) receptor. The association and dissociation rate constants of the agonists were determined using a l-[N-methyl]-[(3)H]scopolamine methyl chloride competition binding assay in the presence of GTP. The agonists displayed a range of association and dissociation rates. Relative agonist efficacy was measured at two points after M(3) receptor activation: the stimulation of guanosine 5'-O-(3-[(35)S]thio)triphosphate binding to G alpha subunits, and the subsequent increase in intracellular calcium levels. These experiments revealed a range of intrinsic efficacy, from the low-efficacy pilocarpine and oxotremorine to high-efficacy acetylcholine. There was no relationship between agonist efficacy and the equilibrium binding affinity of each agonist (K(d)). When efficacy was compared with the dissociation rate constant, however, the two were highly correlated, suggesting a relationship between the duration of agonist binding at the receptor and the intrinsic efficacy. These data suggest that kinetic models incorporating the mean lifetime of specific complexes will be required to fully explain the nature of agonist efficacy.

摘要

尽管有几种实证方法可用于比较相对激动剂效力,但G蛋白偶联受体激动剂引发反应能力差异背后的分子基础仍 largely unexplained。已经描述了几种纳入受体介导的G蛋白循环起始动力学的模型,但这些模型尚未直接解决激动剂结合动力学的影响。为了测试这一点,我们研究了七种M(3)毒蕈碱受体激动剂的效力与其从M(3)受体解离速率(k(off))之间的关系。在存在GTP的情况下,使用l-[N-甲基]-[(3)H]东莨菪碱甲基氯竞争结合试验测定激动剂的结合和解离速率常数。这些激动剂表现出一系列的结合和解离速率。在M(3)受体激活后的两个时间点测量相对激动剂效力:刺激鸟苷5'-O-(3-[(35)S]硫代)三磷酸与Gα亚基的结合,以及随后细胞内钙水平的升高。这些实验揭示了一系列内在效力,从低效的毛果芸香碱和氧化震颤素到高效的乙酰胆碱。每种激动剂的效力与其平衡结合亲和力(K(d))之间没有关系。然而,当将效力与解离速率常数进行比较时,两者高度相关,这表明激动剂在受体上的结合持续时间与内在效力之间存在关系。这些数据表明,需要纳入特定复合物平均寿命的动力学模型来充分解释激动剂效力的本质。

相似文献

1
Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor.探索激动剂效力的机制:毒蕈碱M3受体处效力与激动剂解离速率之间的关系。
Mol Pharmacol. 2009 Sep;76(3):543-51. doi: 10.1124/mol.108.054452. Epub 2009 Jun 4.
2
Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy.配体与 G 蛋白偶联受体结合的负协同性和 GDP 作为激动剂效能的衡量标准。
Br J Pharmacol. 2011 Mar;162(5):1029-44. doi: 10.1111/j.1476-5381.2010.01081.x.
3
New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.新型放射性配体 [³H]iperoxo 对活性毒蕈碱型受体的新认识。
Biochem Pharmacol. 2014 Aug 1;90(3):307-19. doi: 10.1016/j.bcp.2014.05.012. Epub 2014 May 23.
4
Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.乙酰胆碱及其他激动剂与变构配体在毒蕈碱型乙酰胆碱受体上的正协同性。
Mol Pharmacol. 1997 Jul;52(1):172-9. doi: 10.1124/mol.52.1.172.
5
Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling.M2型毒蕈碱型乙酰胆碱受体的定点诱变:酪氨酸403在激动剂结合和功能偶联中的意义。
Mol Pharmacol. 1997 Dec;52(6):1087-94. doi: 10.1124/mol.52.6.1087.
6
Transducer abstraction: a novel approach to the detection of partial agonist efficacy in radioligand binding studies.换能器抽象:放射性配体结合研究中检测部分激动剂效力的新方法。
J Pharmacol Toxicol Methods. 2000 Jan-Feb;43(1):55-67. doi: 10.1016/s1056-8719(00)00078-2.
7
G protein coupling and signaling pathway activation by m1 muscarinic acetylcholine receptor orthosteric and allosteric agonists.M1毒蕈碱型乙酰胆碱受体的正构和变构激动剂介导的G蛋白偶联及信号通路激活
J Pharmacol Exp Ther. 2008 Nov;327(2):365-74. doi: 10.1124/jpet.108.141788. Epub 2008 Jul 29.
8
Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.占诺美林在M3毒蕈碱受体上的抗洗脱结合的即时和延迟后果。
Neurochem Res. 2009 Jun;34(6):1138-49. doi: 10.1007/s11064-008-9886-3. Epub 2008 Dec 12.
9
An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.关于通过Gi/o和Gs蛋白的M2和M4毒蕈碱型乙酰胆碱受体信号传导是否存在激动剂选择性受体构象的研究。
Br J Pharmacol. 2005 Feb;144(4):566-75. doi: 10.1038/sj.bjp.0706090.
10
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.瑞帕库铵对毒蕈碱受体结合及功能变构效应的差异
BMC Pharmacol. 2009 Dec 28;9:15. doi: 10.1186/1471-2210-9-15.

引用本文的文献

1
Noncanonical roles of chemokine regions in CCR9 activation revealed by structural modeling and mutational mapping.通过结构建模和突变定位揭示趋化因子区域在CCR9激活中的非典型作用
Nat Commun. 2025 Aug 18;16(1):7695. doi: 10.1038/s41467-025-62321-9.
2
Residence time in drug discovery: current insights and future perspectives.药物研发中的驻留时间:当前见解与未来展望。
Pharmacol Rep. 2025 Jun 9. doi: 10.1007/s43440-025-00748-z.
3
Quantification of signal amplification for receptors: the /EC ratio of full agonists as a gain parameter.
受体信号放大的定量分析:以完全激动剂的/EC比值作为增益参数。
Front Pharmacol. 2025 Apr 8;16:1541872. doi: 10.3389/fphar.2025.1541872. eCollection 2025.
4
Agonist efficacy at the βAR is driven by the faster association rate of the G protein.β肾上腺素能受体(βAR)上激动剂的效能由G蛋白更快的结合速率驱动。
Front Pharmacol. 2025 Mar 27;16:1367991. doi: 10.3389/fphar.2025.1367991. eCollection 2025.
5
Intracellular Pocket Conformations Determine Signaling Efficacy through the μ Opioid Receptor.细胞内口袋构象通过μ阿片受体决定信号传导效率。
J Chem Inf Model. 2025 Feb 10;65(3):1465-1475. doi: 10.1021/acs.jcim.4c01437. Epub 2025 Jan 17.
6
Intracellular pocket conformations determine signaling efficacy through the opioid receptor.细胞内口袋构象通过阿片受体决定信号传导效率。
bioRxiv. 2024 Dec 7:2024.04.03.588021. doi: 10.1101/2024.04.03.588021.
7
Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition.了解你的分子:候选药物的药理学特征,以提高疗效并减少后期损耗。
Nat Rev Drug Discov. 2024 Aug;23(8):626-644. doi: 10.1038/s41573-024-00958-9. Epub 2024 Jun 18.
8
Development of a membrane-based Gi-CASE biosensor assay for profiling compounds at cannabinoid receptors.用于大麻素受体化合物分析的基于膜的Gi-CASE生物传感器检测方法的开发。
Front Pharmacol. 2023 Aug 11;14:1158091. doi: 10.3389/fphar.2023.1158091. eCollection 2023.
9
Agonist efficiency links binding and gating in a nicotinic receptor.激动剂效率将烟碱型乙酰胆碱受体的结合和门控联系起来。
Elife. 2023 Jul 3;12:e86496. doi: 10.7554/eLife.86496.
10
Immobilization of M3 Muscarinic Receptor to Rapidly Analyze Drug-Protein Interactions and Bioactive Components in a Natural Plant.将 M3 毒蕈碱型乙酰胆碱受体固定化,快速分析天然植物中的药物-蛋白相互作用和生物活性成分。
Int J Mol Sci. 2023 Apr 12;24(8):7171. doi: 10.3390/ijms24087171.